The biopharmaceutical company Ability Pharmaceuticals SL announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator ...
Read moreGenesis Biomed, consultora de referencia en el sector de la biotecnología y la salud, se ha convertido en partner de los consorcios europeos EIT Food y EIT Digital, órganos apoyados por el European ...
Read moreLuis Serrano and Maria Lluch of the Centre for Genomic Regulation (CRG) in Barcelona have founded Pulmobiotics S.L., a pre-clinical life sciences company using synthetic biology to develop new treatme...
Read moreEl objetivo es restaurar la visión clara y mejorar la calidad de vida eliminando el uso de gafas en personas con presbicia
Read moreLa iniciativa está orientada a proyectos que contribuyan a mejorar el diagnóstico y el tratamiento de pacientes, a la gestión de la enfermedad desde el punto de vista sanitario y de protección, as...
Read moreEl dispositivo de diagnóstico desarrollado por Droplite se basa en el concepto lab-on-a-chip y es capaz de realizar pruebas rápidas de tipo inmunoensayo con la fiabilidad de un laboratorio central. ...
Read moreAccure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The funding round ...
Read moreHospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological malignancies. The company raised
Read moreYsios Capital, a leading biotechnology venture capital firm in Spain, today announced its third fund, Ysios BioFund III, with a committed amount of € 155M and a final target size of € 200M.
Read moreThe biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...
Read moreAsabys y Alta han liderado la inversión en INBRAIN para desarrollar una tecnología basada en Grafeno para la modulación electrónica neuronal que permite, tras la implantación intracerebral de un ...
Read moreOna Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with partici...
Read more